Missed blood pressure pills sharply cut protection against heart disease, study finds
Findings presented at the European Society of Cardiology congress show that patients who do not take blood pressure drugs as prescribed gain little cardiovascular protection. A clear benefit appeared only among those taking at least 80% of their assigned medication.
Skipping doses of blood pressure medication substantially weakens its ability to prevent heart attacks, strokes and other serious cardiovascular events, according to results presented at the 2026 congress of the European Society of Cardiology (ESC). The issue is widespread: an estimated 1.4 billion adults aged 30 to 79 live with high blood pressure (hypertension), and roughly half of patients do not take their prescriptions as directed.
How the analysis was done
Qianqian Yang of the University of Oxford in the UK explained that earlier evidence on poor adherence came from observational studies, which can be skewed by other factors. Her team instead analyzed individual patient data from 91,339 participants in nine clinical trials. In each, a blood pressure treatment was compared with either a placebo or a less intensive regimen.
Participants were split into higher adherence (at least 80% of assigned medication taken) and lower adherence (under 80%). Even under the structured conditions of trials, adherence declined over time: 88% of participants met the higher threshold in the first year, but only 79% by the fifth.
Results
Among higher-adherence participants, systolic blood pressure (the top number in a reading) was 5.2 mmHg lower in the treatment group than in the comparison group. For lower-adherence participants, the gap was just 3.0 mmHg. Patients who followed their plans had an 11% lower incidence of major cardiovascular events, including stroke, heart attack, ischemic heart disease, and heart failure leading to hospitalization or death. In the lower-adherence group, the reduction was not statistically significant.
Recommendations
The researchers call for more routine checks of adherence, better patient education and practical measures to make treatment easier to follow. These include simplifying dosing schedules, combining several drugs in one pill, and prescribing longer-acting medicines that limit the effect of an occasional missed dose. Professor Felix Mahfoud, Chair of the ESC Communication Committee, said non-adherence has been neglected as a cause of uncontrolled hypertension and urged clinicians to hold open, non-judgmental conversations with patients about barriers to taking their medication.
